Skip to main content
Category

News Archive

hogan-larry-md-gov-image

Governor Larry Hogan – Official Website for the Governor of Maryland

By News Archive

hogan-larry-md-gov-image

The Maryland Department of Commerce and bwtech@UMBC Research & Technology Park today announced the establishment of an international cybersecurity center, iCyberCenter@bwtech. The governor made the announcement in an address to cyber industry leaders and officials at the Houses of Parliament in London during the administration’s economic development and trade mission to Europe.

Read More
economic-contribution-report-cover-image

The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2015

By News Archive

economic-contribution-report-cover-image

Using an input-output “I-O” approach to estimating the economic impact of academic licensing and summing that impact over 20 years of available data for academic U.S. Association of University Technology Managers (AUTM) Survey respondents, the total contribution of these academic licensors to industry gross output ranges from $320 billion to $1.33 trillion, in 2009 U.S. dollars; and contributions to gross domestic product (GDP) range from $148 billion to $591 billion, in 2009 U.S. dollars. Estimates of the total number of person years of employment supported by U.S. universities’ and hospitals’ and research institutes’ licensed-product sales range from 1.268 million to over 4.272 million over the 20- year period. An explanation of the I-O approach is provided, and the assumptions used and the potential effects of the assumptions on the estimates are discussed. AUTM associated contributions to GDP, calculated using the I-O approach, are compared with U.S. GDP as a whole, and to selected industry, as defined by North American Industry Classification System (NAICS) codes, contributions to GDP. Factors affecting the AUTM contributions to GDP appear to differ from those affecting U.S. GDP as a whole, as well as from those affecting selected NAICS industry contributions to GDP.

Read More
bioscience-innovaiton-bio-report-image

BIOSCIENCE INNOVATION IN THE STATES: LEGISLATION AND JOB CREATION THROUGH PUBLIC-PRIVATE PARTNERSHIPS

By News Archive

bioscience-innovaiton-bio-report-image

Advances in biotechnology innovation have had an enormous transformative impact on many sectors of the U.S. economy — life-saving drugs for patients of all ages, protecting plants that are key to feeding the world and industrial biotechnology applications that are leading to bio-based fuels, chemicals and products that can protect our environment.

The bioscience’s need for a stable and supportive public policy framework is vital to industry firms large and small. It is almost impossible for any state or region to ignore the need for selective incentives to either hold existing bioscience companies or attract new enterprises.

Read More
GlaxoSmithKline-gsk-logo

Lupus Therapy Benlysta Achieves Sustained Disease Control, Concludes 10-year GSK Study

By News Archive

GlaxoSmithKline-gsk-logo

Patients with active systemic lupus erythematosus (SLE) were able to control their disease with Benlysta (belimumab) plus standard of care (prednisone), pharmaceutical giant GSK said in announcing the results from a 10-year continuation study.

GSK presented the study’s results at the Annual European Congress of Rheumatology (EULAR 2017), held June 14-17 in Madrid.

Read More
nea-62617-logo

NEA makes history with $3.3B fund | PitchBook News

By News Archive

nea-62617-logo

New Enterprise Associates has closed its 16th flagship fund on $3.3 billion, per the Wall Street Journal, the largest venture vehicle ever raised.

A monumental fundraise, yes, but billion-dollar funds are nothing new for NEA—its latest vehicle also represents the firm’s seventh consecutive $1-billion-plus venture fund. In 1978, NEA closed its first fund on $16 million. The firm has gone on to garner $17 billion in committed capital across 15 funds, not including NEA 16. Here’s a look at the firm’s largest funds to date, according to the PitchBook Platform:

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.